» Articles » PMID: 22233266

Collection and Storage of Red Blood Cells with Anticoagulant and Additive Solution with a Physiologic PH

Overview
Journal Transfusion
Specialty Hematology
Date 2012 Jan 12
PMID 22233266
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A donation of whole blood is most commonly collected in acidic citrate-phosphate-dextrose (CPD) variants with pH 5.2 to 6.2 as anticoagulants. Previously, we have shown that the initial pH after red blood cell (RBC) preparation can have an effect on RBCs during storage. First, we investigated the effect of the pH of the anticoagulant on RBCs. Second, we investigated the possibility of decreasing the pH of our new additive solution (AS) phosphate-adenine-glucose-guanosine-gluconate-mannitol (PAGGGM) from pH 8.2 to 7.4 in combination with an anticoagulant with a physiologic pH.

Study Design And Methods: Whole blood was collected in CPD (pH 5.6) or trisodiumcitrate (TNC; pH 7.4), and leukoreduced units were prepared using saline-adenine-glucose-mannitol as AS. Second, whole blood was collected in TNC (pH 7.4), and leukoreduced units were prepared using PAGGGM (pH 7.4) or PAGGGM (pH 8.2) as AS. During cold storage, several in vitro characteristics were analyzed.

Results: In agreement with our previous findings, the initial pH of whole blood has an effect during storage of RBCs. In the second part we show that there are no differences between PAGGGM (pH 7.4) and PAGGGM (pH 8.2) units when an anticoagulant with a physiologic pH was used.

Conclusion: These results indicate that the pH of the anticoagulant used during whole blood collection has an effect during storage of RBCs. When an anticoagulant with a physiologic pH is used during whole blood collection, the pH of PAGGGM can be decreased to physiologic levels, while maintaining adenosine triphosphate and 2,3-diphosphoglycerate levels.

Citing Articles

Impact of Different Red Blood Cell Storage Solutions and Conditions on Cell Function and Viability: A Systematic Review.

Tran L, Gonzalez-Fernandez C, Gomez-Pastora J Biomolecules. 2024; 14(7.

PMID: 39062526 PMC: 11274915. DOI: 10.3390/biom14070813.


Recent advances in micro-sized oxygen carriers inspired by red blood cells.

Zhang Q, Inagaki N, Ito T Sci Technol Adv Mater. 2023; 24(1):2223050.

PMID: 37363800 PMC: 10288928. DOI: 10.1080/14686996.2023.2223050.


A deep 96-well plate RBC storage platform for high-throughput screening of novel storage solutions.

Nikulina M, Nemkov T, DAlessandro A, Gaccione P, Yoshida T Front Physiol. 2022; 13:1004936.

PMID: 36277188 PMC: 9583842. DOI: 10.3389/fphys.2022.1004936.


Prevention of red cell storage lesion: a comparison of five different additive solutions.

Lagerberg J, Korsten H, van der Meer P, de Korte D Blood Transfus. 2017; 15(5):456-462.

PMID: 28488968 PMC: 5589708. DOI: 10.2450/2017.0371-16.


Differences in Rat and Human Erythrocytes Following Blood Component Manufacturing: The Effect of Additive Solutions.

da SilveiraCavalcante L, Acker J, Holovati J Transfus Med Hemother. 2015; 42(3):150-7.

PMID: 26195928 PMC: 4483285. DOI: 10.1159/000371474.